Prefabrication of Vascularized Allogenic Bone Graft in a Rat by Implanting a Flow-Through Vascular Pedicle and Basic Fibroblast Growth Factor Containing Hydroxyapatite/Collagen Composite

Abstract

Background Basic fibroblast growth factor (bFGF) is known to stimulate bone formation and angiogenesis. Hydroxyapatite/collagen composite (HAp/Col) is also known to have very strong bone conductive activity. In this study, prefabrication of vascularized allogenic bone (allo-bone) graft was attempted in recipients by implanting vascular bundles from recipients into the transplanted allo-bone graft. Furthermore, the effect of bFGF-containing HAp/Col on the prefabricated vascularized allo-bone graft was investigated.

Methods In this study, 32 Sprague-Dawley rats were used as donors, and bone grafts were collected from their femora. Thirty-two Wistar rats (recipients) were divided into four groups, and the allo-bone grafts were transplanted into the thigh region. In the experimental groups, one or both of the flow-through saphenous vascular bundles and 100-μg bFGF-containing HAp/Col were implanted into the medullary cavity of the allo-bone grafts. In the control group, neither was implanted. These rats were sacrificed at 4 weeks after transplantation, and bone formation, angiogenesis, and bone resorption in the transplanted allo-bone grafts were evaluated histologically and genetically.

Results Bone formation and angiogenesis in the transplanted allo-bone graft were effectively stimulated by implanting vascular bundles or bFGF-containing HAp/Col on both histological and genetic evaluations compared with the control group. The most significant stimulation was observed in the group in which both were implanted. Bone resorption was not stimulated in any group.

Conclusion By implanting a flow-through vascular bundle and bFGF-containing HAp/Col, an ideal vascularized allo-bone graft that had high bone formative and angiogenetic activities and did not stimulate bone resorptive activity was prefabricated.

Keywords

allo-bone graft - bFGF - hydroxyapatite/collagen

• References

• 1 Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin Orthop Relat Res 1987; (225) 7-16
• 2 Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996; (329) 300-309
• 3 Doi K, Akino T, Shigetomi M, Muramatsu K, Kawai S. Vascularized bone allografts: review of current concepts. Microsurgery 1994; 15 (12) 831-841
• 4 Weiland AJ. Current concepts review: vascularized free bone transplants. J Bone Joint Surg Am 1981; 63 (1) 166-169
• 5 Ceruso M, Falcone C, Innocenti M, Delcroix L, Capanna R, Manfrini M. Skeletal reconstruction with a free vascularized fibula graft associated to bone allograft after resection of malignant bone tumor of limbs. Handchir Mikrochir Plast Chir 2001; 33 (4) 277-282
• 6 Capanna R, Campanacci DA, Belot N , et al. A new reconstructive technique for intercalary defects of long bones: the association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques. Orthop Clin North Am 2007; 38 (1) 51-60 , vi
• 7 Capanna R, Bufalini C, Campanacci M. A new technique for reconstructions of large metadiaphyseal bone defects. Orthop Trauma 1993; 2 (3) 159-177
• 8 Doi K, Tominaga S, Shibata T. Bone grafts with microvascular anastomoses of vascular pedicles: an experimental study in dogs. J Bone Joint Surg Am 1977; 59 (6) 809-815
• 9 Venkatramani H, Sabapathy SR, Dheenadayalan J, Devendra A, Rajasekaran S. Reconstruction of post-traumatic long segment bone defects of the lower end of the femur by free vascularized fibula combined with allograft (modified Capanna's technique). Eur J Trauma Emerg Surg 2015; 41 (1) 17-24
• 10 Nakamura O, Kaji Y, Imaizumi Y, Yamagami Y, Yamamoto T. Prefabrication of vascularized bone allograft in a recipient rat using a flow-through vascular pedicle, bone morphogenetic protein, and bisphosphonate. J Reconstr Microsurg 2013; 29 (4) 241-248
• 11 Kawaguchi H, Nakamura K, Tabata Y , et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86 (2) 875-880
• 12 Jimi E, Shuto T, Ikebe T, Jingushi S, Hirata M, Koga T. Basic fibroblast growth factor inhibits osteoclast-like cell formation. J Cell Physiol 1996; 168 (2) 395-402
• 13 Kimura A, Kabasawa Y, Tabata Y, Aoki K, Ohya K, Omura K. Gelatin hydrogel as a carrier of recombinant human fibroblast growth factor-2 during rat mandibular distraction. J Oral Maxillofac Surg 2014; 72 (10) 2015-2031
• 14 Kimura Y, Ozeki M, Inamoto T, Tabata Y. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng 2002; 8 (4) 603-613
• 15 Song J, Leeuwenburgh SC. Sustained delivery of biomolecules from gelatin carriers for applications in bone regeneration. Ther Deliv 2014; 5 (8) 943-958
• 16 Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 1999; 5 (2) 127-138
• 17 Sato M, Ishihara M, Ishihara M , et al. Effects of growth factors on heparin-carrying polystyrene-coated atelocollagen scaffold for articular cartilage tissue engineering. J Biomed Mater Res B Appl Biomater 2007; 83 (1) 181-188
• 18 Kikuchi M, Ikoma T, Syoji D , et al. Porous body preparation of hydroxyapatite/collagen nanocomposites for bone tissue regeneration. Key Eng Mater 2004; 254–256: 561-564
• 19 Sotome S, Orii H, Kikuchi M , et al. In vivo evaluation of porous hydroxyapatite/collagen composite as a carrier of OP-1 in a rabbit PLF model. Key Eng Mater 2006; 309–311: 977-980
• 20 Choi S, Lee J, Igawa K , et al. Effect of trehalose coating on basic fibroblast growth factor release from tailor-made bone implants. J Vet Med Sci 2011; 73 (12) 1547-1552
• 21 Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J. Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 2001; 22 (13) 1705-1711
• 22 Itoh S, Kikuchi M, Takakuda K , et al. The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2. J Biomed Mater Res 2001; 54 (3) 445-453
• 23 Kikuchi M. Hydroxyapatite/collagen bone-like nanocomposite. Biol Pharm Bull 2013; 36 (11) 1666-1669
• 24 Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 2007; 89 (5) 693-700
• 25 Vittayakittipong P, Jarudejkajon J, Kirirat P, Chaijaroonkhanarak W, Chaisiwamongkol K. Feasibility of the vascularized fibula bone graft for reconstruction of the mandible: a cadaveric study. Int J Oral Maxillofac Surg 2016; 45 (8) 960-963
• 26 Han CS, Wood MB, Bishop AT, Cooney III WP. Vascularized bone transfer. J Bone Joint Surg Am 1992; 74 (10) 1441-1449
• 27 Campanacci DA, Capanna R, Ceruso M , et al , eds. Indications for combined grafts (allografts + vascularized fibula) after intercalary resections for bone tumor. In: Czitrom AA, Winkler H, , eds. Orthopaedic Allograft Surgery. New York, NY: Springer-Verlag/Wein; 1996: 149-155
• 28 Andreopoulos FM, Persaud I. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 2006; 27 (11) 2468-2476
• 29 Cai S, Liu Y, Zheng Shu X, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005; 26 (30) 6054-6067
• 30 Freudenberg U, Hermann A, Welzel PB , et al. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials 2009; 30 (28) 5049-5060
• 31 Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991; 12 (7) 619-626
• 32 Masaoka T, Yamada T, Yuasa M , et al. Biomechanical evaluation of the rabbit tibia after implantation of porous hydroxyapatite/collagen in a rabbit model. J Orthop Sci 2016; 21 (2) 230-236
• 33 Pri-Chen S, Pitaru S, Lokiec F, Savion N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 1998; 23 (2) 111-117